NICE publishes draft update to Fertility Guideline
By Georgia Brice,
BioNews
| 09. 15. 2025
The National Institute for Health and Care Excellence (NICE) recommends three NHS-funded IVF cycles for those eligible under 40, with potential for three more if unsuccessful, in a proposed guideline update.
Since 2004, NICE has recommended that the NHS should provide three full cycles of IVF to any woman (under 40 years of age) who meets certain eligibility criteria. In a long-awaited draft revision of its Fertility Guideline, NICE has retained this recommendation, adding that professionals should 'consider' offering 'up to three further full cycles of IVF treatment', if the first three cycles have not been successful and if the patient has not yet reached 40.
'The evidence considered by our committee demonstrates that providing three IVF cycles to women under 40 with fertility problems offers them a good chance of a successful pregnancy,' said Professor Jonathan Benger, chief medical officer and interim director of the centre for guidelines at NICE.
However, the Fertility Policy Tracker maintained by PET (the Progress Educational Trust) shows that 40 out of 42 Integrated Care Boards (ICBs) in England currently fail to...
Related Articles
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Robyn Vinter, The Guardian | 11.09.2025
A man going by the name “Rod Kissme” claims to have “very strong sperm”. It may seem like an eccentric boast for a Facebook profile page, but then this is no mundane corner of the internet. The group where Rod...